Medtronic (MDT) 10-K Summary — Year Ended Apr 26, 2024
Medtronic plc filed its annual report covering the most recent fiscal period. The filing discusses financial results, liquidity, and capital allocation.
Key takeaway
Year ended Apr 26, 2024 · FY2026 10-K
Medtronic plc filed its annual report covering the most recent fiscal period. The filing discusses financial results, liquidity, and capital allocation.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$32.4B
Revenue reported for the fiscal year.
Operating income
$5.1B
Income from operations reported for the year.
Net income
$3.7B
Net income reported for the year.
Operating cash flow
$6.8B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Apr 29, 2022 | $31.7B | n/a |
| Apr 28, 2023 | $31.2B | -1.4% |
| Apr 26, 2024 | $32.4B | +3.6% |
Business overview
Medtronic plc is a medical technology company. Its operations involve significant investment in research and development and manufacturing infrastructure. The company focuses on developing and delivering therapies and devices.
Financial performance
Revenue increased compared to the prior year. Operating income and net income were reported, and operating cash flow was positive. The company's financial performance reflects its operational activities.
Material risks
The company faces risks from foreign currency exchange rate fluctuations. Market risks are also disclosed. These factors could impact financial results.
Liquidity and capital
The company allocates capital to dividends, share repurchases, debt repayment, and acquisitions. It maintains a strong liquidity position to support these activities.
What to watch
Monitor the company's revenue growth and operating cash flow trends in the next filing.